Literature DB >> 20472479

Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.

Juan J Bustamante1, Alexei L Grigorian, Jesus Muñoz, Roberto M Aguilar, Lisa R Treviño, Andrew O Martinez, Luis S Haro.   

Abstract

BACKGROUND: Human growth hormone (hGH) is a complex mixture of molecular isoforms. Gaps in our knowledge exist regarding the structures and biological significances of the uncharacterized hGH molecular variants. Mercaptoethanol-resistant 45-kDa human growth hormone (MER-45 kDa hGH) is an extraordinarily stable disulfide-linked hGH homodimer whose biological significance is unknown.
OBJECTIVES: To elucidate the pharmacokinetic abilities of dimeric MER-45-kDa hGH to bind to GH and prolactin (PRL) receptors and to elucidate its abilities to stimulate cell proliferation in lactogen-induced and somatogen-induced in vitro cell proliferation bioassays.
DESIGN: The binding of MER-45-kDa hGH to GH and PRL receptors was tested in radioreceptor assays (RRAs). Competitive displacements of [(125)I]-bovine GH from bovine liver membranes, [(125)I]-ovine PRL from lactating rabbit mammary gland membranes and [(125)I]-hGH from human IM-9 lymphocytes by unlabelled GHs, PRLs or dimeric MER-45-kDa hGH were evaluated. The abilities of dimeric MER-45-kDa hGH to stimulate proliferation of lactogen-responsive Nb2 lymphoma cells and to stimulate proliferation of somatogen-responsive T47-D human breast cancer cells were assessed by incubation of cells with GHs or PRLs and subsequently measuring growth using the MTS cell proliferation assay.
RESULTS: Dimeric MER-45-kDa hGH, compared to monomeric hGH, had reduced binding affinities to both GH and prolactin receptors. In a bovine liver GH radioreceptor assay its ED(50) (197.5 pM) was 40.8% that of monomeric hGH. In a human IM-9 lymphocyte hGH RRA its ED(50) (2.96 nM) was 26.2% that of monomeric hGH. In a lactating rabbit mammary gland prolactin RRA its ED(50) (3.56 nM) was 16.8% that of a monomeric hGH. Dimeric MER-45-kDa hGH, compared to monomeric hGH, had a diminished capacity to stimulate proliferation of cells in vitro. In a dose-response relationship assessing proliferation of Nb2 lymphoma cells its ED(50) (191 pM) was 18.0% that of monomeric hGH. While monomeric hGH stimulated a 2.2-fold proliferation of T47-D human breast cancer cells above vehicle control, dimeric MER-45-kDa hGH was unable to stimulate the cells to proliferate and slightly inhibited their proliferation to 77.6% that of control.
CONCLUSIONS: The topological arrangement of monomeric hGHs to form an unusually stable disulfide-linked dimer markedly diminishes hGH's binding affinities to both GH and PRL receptors and also drastically attenuates its ability to stimulate proliferation of cells in vitro. Copyright 2010 Growth Hormone Research Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472479      PMCID: PMC2918732          DOI: 10.1016/j.ghir.2010.03.007

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  46 in total

1.  Proteomics analysis of growth hormone isoforms in the human pituitary.

Authors:  Xianquan Zhan; Francesco Giorgianni; Dominic M Desiderio
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

Review 2.  Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins.

Authors:  G Baumann
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

3.  An interchain disulfide dimer of human growth hormone.

Authors:  U J Lewis; S M Peterson; L F Bonewald; B K Seavey; W P VanderLaan
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

4.  Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.

Authors:  Y Ohmae; H Yano; S Umezawa; T Tanaka; I Hibi; C Miyamoto; Y Furuichi
Journal:  Endocrinol Jpn       Date:  1989-02

5.  Extraordinarily stable disulfide-linked homodimer of human growth hormone.

Authors:  Alexei L Grigorian; Juan J Bustamante; Peter Hernandez; Andrew O Martinez; Luis S Haro
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

Review 6.  Growth hormone as an early embryonic growth and differentiation factor.

Authors:  Esmond J Sanders; Steve Harvey
Journal:  Anat Embryol (Berl)       Date:  2004-11

7.  Hydrophobic residues involved in the interaction between protomers of the bovine growth hormone dimer. Methionine and tyrosine residues.

Authors:  O J Oppezzo; M Biscoglio de Jiménez Bonino; O Cascone; C Nowicki; V Blumgrund; J A Santomé; H N Fernández
Journal:  Acta Physiol Pharmacol Latinoam       Date:  1984

8.  A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

Authors:  T Tanaka; R P Shiu; P W Gout; C T Beer; R L Noble; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

9.  Altered proteolytic cleavage of human growth hormone as a result of deamidation.

Authors:  U J Lewis; R N Singh; L F Bonewald; B K Seavey
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

10.  Covalent cross-linking of the bovine somatotropin dimer. Effects on growth-promoting, receptor-binding and immunological activities and preliminary characterization of the self-association.

Authors:  H N Fernández; J M Delfino
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

View more
  4 in total

1.  Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state.

Authors:  Saradha Chandrasekhar; Elizabeth M Topp
Journal:  J Pharm Sci       Date:  2015-01-28       Impact factor: 3.534

2.  Thiol-disulfide exchange in peptides derived from human growth hormone.

Authors:  Saradha Chandrasekhar; Daniel E Epling; Andreas M Sophocleous; Elizabeth M Topp
Journal:  J Pharm Sci       Date:  2014-02-18       Impact factor: 3.534

3.  Growth hormone is a cellular senescence target in pituitary and nonpituitary cells.

Authors:  Vera Chesnokova; Cuiqi Zhou; Anat Ben-Shlomo; Svetlana Zonis; Yuji Tani; Song-Guang Ren; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

Review 4.  Growth hormone: isoforms, clinical aspects and assays interference.

Authors:  Júnia Ribeiro de Oliveira Longo Schweizer; Antônio Ribeiro-Oliveira; Martin Bidlingmaier
Journal:  Clin Diabetes Endocrinol       Date:  2018-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.